OBJECTIVE: To evaluate the relationship between chronic glucocorticoid (GC) exposure and bone mineral density (BMD) in children with rheumatic diseases and inflammatory bowel disease. STUDY DESIGN: Lumbar spine BMD was measured by DXA in 86 GC-treated children (66% female, age 8-20 years, mixed ethnicity) screened for a multi-center intervention trial. Predictors of spine BMD z-score and vitamin D [25(OH)D] were examined by multivariable linear regression. RESULTS: Mean prior year and lifetime cumulative GC exposure was 77.8 mg/kg and 224.6 mg/kg, respectively. BMD z-scores ranged from -3.7 to 2.2 SD (-1.1 +/- 1.2, mean +/- SD). Lower BMD z-scores were associated with increased prior year average daily GC dose (p = 0.03), decreased height z-score (p = 0.003), and decreased 25(OH)D concentrations (p = 0.03), but explained only a small proportion of BMD variability (adjusted R2 = 0.29). The 25(OH)D levels were <20 ng/ml in 45% of patients, and low 25(OH)D was associated with non-Caucasian ethnicity (p <0.001), increased age (p = 0.004), increased parathyroid hormone (p = 0.03), and residing in the Boston area (p <0.001). CONCLUSIONS: Although GC exposure is significantly associated with BMD z-score, the association is too variable to serve as a consistent predictor of reduced BMD in children. Vitamin D insufficiency is common and may contribute to skeletal deficits in this population.
OBJECTIVE: To evaluate the relationship between chronic glucocorticoid (GC) exposure and bone mineral density (BMD) in children with rheumatic diseases and inflammatory bowel disease. STUDY DESIGN: Lumbar spine BMD was measured by DXA in 86 GC-treated children (66% female, age 8-20 years, mixed ethnicity) screened for a multi-center intervention trial. Predictors of spine BMD z-score and vitamin D [25(OH)D] were examined by multivariable linear regression. RESULTS: Mean prior year and lifetime cumulative GC exposure was 77.8 mg/kg and 224.6 mg/kg, respectively. BMD z-scores ranged from -3.7 to 2.2 SD (-1.1 +/- 1.2, mean +/- SD). Lower BMD z-scores were associated with increased prior year average daily GC dose (p = 0.03), decreased height z-score (p = 0.003), and decreased 25(OH)D concentrations (p = 0.03), but explained only a small proportion of BMD variability (adjusted R2 = 0.29). The 25(OH)D levels were <20 ng/ml in 45% of patients, and low 25(OH)D was associated with non-Caucasian ethnicity (p <0.001), increased age (p = 0.004), increased parathyroid hormone (p = 0.03), and residing in the Boston area (p <0.001). CONCLUSIONS: Although GC exposure is significantly associated with BMD z-score, the association is too variable to serve as a consistent predictor of reduced BMD in children. Vitamin Dinsufficiency is common and may contribute to skeletal deficits in this population.
Authors: R Eastell; D M Reid; J Compston; C Cooper; I Fogelman; R M Francis; D J Hosking; D W Purdie; S H Ralston; J Reeve; R G Russell; J C Stevenson; D J Torgerson Journal: J Intern Med Date: 1998-10 Impact factor: 8.989
Authors: Khayriah A Alsufyani; Olivia Ortiz-Alvarez; David A Cabral; Lori B Tucker; Ross E Petty; Helen Nadel; Peter N Malleson Journal: J Rheumatol Date: 2005-04 Impact factor: 4.666
Authors: T C M de Castro; M T R A Terreri; V L Szejnfeld; C Len; A S M da Fonseca; M O E Hilário Journal: Braz J Med Biol Res Date: 2005-02-15 Impact factor: 2.590
Authors: Alon D Levin; Veena Wadhera; Steven T Leach; Helen J Woodhead; Daniel A Lemberg; A Czarina Mendoza-Cruz; Andrew S Day Journal: Dig Dis Sci Date: 2011-01-11 Impact factor: 3.199
Authors: Darrell M Wilson; Stephanie H Abrams; Tandy Aye; Phillip D K Lee; Carine Lenders; Robert H Lustig; Stavroula V Osganian; Henry A Feldman Journal: Arch Pediatr Adolesc Med Date: 2010-02
Authors: Carine M Lenders; Henry A Feldman; Emily Von Scheven; Anne Merewood; Carol Sweeney; Darrell M Wilson; Phillip D K Lee; Stephanie H Abrams; Stephen E Gitelman; Marcia S Wertz; William J Klish; George A Taylor; Tai C Chen; Michael F Holick Journal: Am J Clin Nutr Date: 2009-07-29 Impact factor: 7.045